FDA Names Former Pharmaceutical Company Executive to Oversee US Drug Program

FDA picks George Tidmarsh to head Center for Drug Evaluation and Research

The U.S. Food and Drug Administration has appointed George Francis Tidmarsh, M.D., Ph.D., as director of the Center for Drug Evaluation and Research (CDER).

Who is Dr. George Tidmarsh, the new director of CDER?

Despite past criticism of public health policies, Tidmarsh recently praised the FDA and said he’ll focus on boosting review efficiencies.

Linda Boyle: FDA green lights Spikevax for young children, raising questions on safety, transparency

By LINDA BOYLE During his Senate confirmation, FDA Commissioner Dr. Martin Makary said that no more mRNA Covid boosters would be approved without adequate scientific data. Gone were the days when the Centers for Disease Control and Prevention would just rubber-stamp the newest and greatest booster jabs Big Pharma had developed. And no longer would […] The post Linda Boyle: FDA green lights Spikevax for young children, raising questions on safety…

Why was a Big Pharma bigwig tapped for top FDA post?

Health and Human Services Secretary Robert F. Kennedy Jr. has been throwing a fit over Food and Drug Administration regulators for years.� Setting aside Kennedy’s congenital inability to tell the ...

FDA Names George Tidmarsh as Top Drug Regulator

The Food and Drug Administration announced on July 21 that a former pharmaceutical executive will direct its drug evaluation center. Dr. George Tidmarsh, an adjunct professor at Stanford University, will lead the FDA’s Center for Drug Evaluation and Research (CDER), the FDA said in a statement. Tidmarsh was president and CEO of La Jolla Pharmaceutical Company from early 2012 until late 2019, during which time the company secured FDA approval of …

FDA Appoints Biotech Exec as Top Drug Regulator